2015
DOI: 10.1016/j.fertnstert.2015.03.027
|View full text |Cite
|
Sign up to set email alerts
|

Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
15
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(17 citation statements)
references
References 30 publications
2
15
0
Order By: Relevance
“…Increased expression of CB1 in WAT is associated with hyperinsulinaemia, which is restored by CB1 antagonist administration (69) . In the present study, we observed increased CB1 and hyperinsulinaemia only in female HF offspring, which may contribute to insulin resistance (70,71) . CB1 expression in adipocytes is down-regulated by PPARγ (72) , and maternal HF diet decreased PPARγ content in the VIS WAT of female offspring.…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…Increased expression of CB1 in WAT is associated with hyperinsulinaemia, which is restored by CB1 antagonist administration (69) . In the present study, we observed increased CB1 and hyperinsulinaemia only in female HF offspring, which may contribute to insulin resistance (70,71) . CB1 expression in adipocytes is down-regulated by PPARγ (72) , and maternal HF diet decreased PPARγ content in the VIS WAT of female offspring.…”
Section: Discussionsupporting
confidence: 55%
“…Increased expression of CB1 in WAT is associated with hyperinsulinaemia, which is restored by CB1 antagonist administration ( 69 ) . In the present study, we observed increased CB1 and hyperinsulinaemia only in female HF offspring, which may contribute to insulin resistance ( 70 , 71 ) .…”
Section: Discussionsupporting
confidence: 55%
“…The finding that metabolic risk factors are less severe in cannabis users compared to non-users could be explained by the interaction of cannabis with the endocannabinoid system via the cannabinoid type 1 (CB1) and cannabinoid type 2 (CB2) receptor. Over-activity of the endocannabinoid system is associated with an increased risk of developing abdominal obesity, hyperglycemia and dyslipidemia (Juan et al, 2015;Matias and Di Marzo, 2007). The main psychoactive constituent of cannabis (−)-trans-Δ 9 -tetrahydrocannabinol (THC) is a CB1 receptor agonist, which increases appetite and food intake and stimulates the storage of body fat (Di Marzo and Matias, 2005;Hillig and Mahlberg, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…In a nonpregnant canine model and in lean and obese human subjects, a HFD did not affect AEA but did decrease 2-AG concentrations (27,79). In contrast, 2-AG concentrations were increased in obesity and hyperphagia associated with Prader-Willi syndrome (45), in obese postmenopausal women with insulin resistance (1), and in women with polycystic ovarian syndrome (40). These controversial effects could be explained in part by the differences in insulin sensitivity in the different obesity-and HFD-related phenotypes; e.g., decreased insulin sensitivity is associated with increased 2-AG levels (1).…”
Section: Maternal Systemic and Hepatic Ecs Responses To Hfdmentioning
confidence: 90%